Collegium Pharmaceutical (NasdaqGS:COLL) FY Conference Transcript

Collegium Pharmaceutical (NasdaqGS:COLL) FY Conference December 02, 2025 02:30 PM ET Company ParticipantsColleen Tupper - CFOVikram Karnani - CEOConference Call ParticipantsDavid Amsellem - Managing Director and Senior Research AnalystDavid AmsellemOkay, let's get started. Good afternoon everyone. This is David Amsellem from the Piper Sandler Biopharma team. Our next company fireside chat is Collegium. We have CEO Vikram Karnani with us. We also have CFO Colleen Tupper. Thanks so much for joining us. Let's ...